NEW YORK ( TheStreet) -- The maker of the Invisalign teeth straightening system, Align Technology (ALGN) ended Wednesday's trading session down 3.8% to $20.37 after agreeing to acquire dentistry imaging company Cadent for $190 million.
Apollo Global Management (APO) fell 4.2% to $18.20 following rousing reception of the private-equity firm's long-awaited initial public offering Tuesday. On Wednesday, Thomson Reuters releases data highlighting mixed IPO results from Apollo's portfolio companies.
>> Apollo's IPO Gets Warm Reception
Palo Alto, Calif.-based cloud computing application maker Tibco Software (TIBX) rose 1.8% at $26.74 after edging past Wall Street's expectations for its fiscal first-quarter results. While Tibco's performance was ahead of the consensus view, the magnitude of the beat was only 5% vs. a 16% average beat in the previous eight quarters.
>> Tibco Software: After-Hours Trading
Wal-Mart (WMT) rose 0.2% to $52.36 after a visiting positive territory as judges expressed skepticism about a large class-action lawsuit against the giant retailer over sex discrimination.
Phosphate and potash company Mosaic (MOS) ended up 2% to $80.45 ahead of its third-quarter earnings report after the markets close Wednesday.
Chemicals company DuPont (DD) added 1.4% to $55.37 after its subsidiary DuPont Denmark extended a $6 billion offer for food ingredients company Danisco to April 29 to allow for additional time to obtain regulatory approvals in the European Union and China. So far, shareholders representing a mere 6% stake in Danisco have accepted DuPont's offer, 90% short of the acceptances the buyer would have needed to meet its original offer closing date of April 1.
Drug company Cephalon (CEPH) is facing a hostile bid from Valeant Pharmaceuticals (VRX), which is offering $73 a share, a 24% premium to Cephalon's closing price Tuesday of $58.75. Cephalon shares surged 28.4% to $75.44 Wednesday. Shares of Valeant popped 12.8% to $50.08.
>> Valeant Goes Hostile With Cephalon Bid
Investment manager BlackRock (BLK) advanced 6.6% to $198.84 as it replaces biotech company Genzyme (GENZ) in the S&P 500 after the markets close on Friday.
Discount store chain Family Dollar (FDO) fell 0.3% to $52.25 as investors took profits after the company reported second-quarter earnings of 98 cents a share. The earnings beat narrowly expectations by a penny. >>Search for Highest Dividends by Rate or Yield
|More on Earnings Today's Top Earnings|
>To contact the writer of this article, click here: Andrea Tse. >To follow the writer on Twitter, go to Andrea Tse. >To submit a news tip, send an email to: firstname.lastname@example.org.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV